Symptomlinderung durch Tumortherapie?

Author:

Alt-Epping B.,Haas A.-L.,Jansky M.,Nauck F.

Publisher

Springer Science and Business Media LLC

Subject

Anesthesiology and Pain Medicine,Neurology (clinical)

Reference71 articles.

1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376

2. Alt-Epping B, Jung W, Nauck F (2007) Symptomkontrollierende Effekte der Chemotherapie. Onkologe 13:619–624

3. Anderson H, Hopwood P, Stephens RJ, Thatcher N, Cottier B, Nicholson M, Milroy R, Maughan TS, Falk SJ, Bond MG et al (2000) Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer – a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Br J Cancer 83:447–453

4. Anderson J, Al-Ali G, Wirth M, Gual JB, Gomez Veiga F, Colli E, van der Meulen E, Persson B‑E (2013) Degarelix versus goserelin (+ antiandrogen flare protection) in the relief of lower urinary tract symptoms secondary to prostate cancer: results from a phase IIIb study (NCT00831233). Urol Int 90:321–328

5. Alt-Epping B, Seidel W, Vogt J, Mehnert A, Thomas M, van Oorschot B, Wolff H, Schliephake H, Canis M, Dröge LH, Nauck F, Lordick F, Arbeitsgemeinschaft Palliativmedizin (APM) of the German Cancer Society (DKG) (2016) Symptoms and needs of head and neck cancer patients at diagnosis of incurability – prevalences, clinical implications and feasibility of a prospective longitudinal multicenter cohort study. Oncol Res Treat 39:186–191

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Übertherapie am Lebensende;Repetitorium Palliativmedizin;2023

2. Wenn finanzielle Interessen vor dem Patientenwohl stehen;Schmerzmedizin;2019-05

3. Palliative Care;Radiation Oncology;2019

4. Palliative Care;Radiation Oncology;2019

5. Übertherapie am Lebensende;Repetitorium Palliativmedizin;2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3